• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: New insider Aikawa Yoshiyuki claimed ownership of 94,192,433 shares (SEC Form 3)

    4/9/25 7:00:13 AM ET
    $SBC
    Medical/Nursing Services
    Health Care
    Get the next $SBC alert in real time by email
    SEC FORM 3/A SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Aikawa Yoshiyuki

    (Last) (First) (Middle)
    C/O SBC MEDICAL GROUP HOLDINGS INC
    200 SPECTRUM CENTER DR., SUITE 300

    (Street)
    IRVINE CA 92618

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    09/17/2024
    3. Issuer Name and Ticker or Trading Symbol
    SBC Medical Group Holdings Inc [ SBC ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    Chairman and CEO
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    09/17/2024
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock, par value $0.0001 per share 94,192,433(1) D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This Form 3/A is being filed to amend and restate the original Form 3 filed by the reporting person on September 17, 2024 (the "Original Form 3") to correct the amount of securities reported as beneficially owned by the reporting person as of the filing of the Original Form 3. This amendment is also deemed to update the number of securities reported as beneficially owned by the reporting person on the subsequently filed Form 4 on September 17, 2024. As of the date of this amendment, the reporting person beneficially owns 92,688,960 shares of common stock.
    Remarks:
    Exhibit 24 - Power of Attorney
    /s/ Yuya Yoshida, Attorney-in-Fact 04/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SBC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SBC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SBC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

      IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

      7/1/25 8:00:00 AM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • SBC Medical added to membership of Russell 3000® Index

      SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style inde

      6/27/25 7:30:00 PM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • SBC Medical Participated in 4 Investor Conferences in May and June 2025

      IRVINE, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, recently participated in several prominent investor conferences throughout May and June 2025. SBC Medical delivered webcast presentations and conducted one-on-one meetings with institutional investors. Presentation videos can be viewed at the links below:https://youtu.be/sM8VzxrQpac?feature=sharedBelow is a summary of the Company's participation in recent investor conferences: Zacks SCR Life Sciences Virtual Investor ForumMain Speaker: Yuya Yoshida (CFO)Date: June 12, 2025Sidoti Small-Cap Virtual Confere

      6/23/25 1:06:37 AM ET
      $SBC
      Medical/Nursing Services
      Health Care

    $SBC
    SEC Filings

    See more
    • SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

      6/30/25 6:07:19 AM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

      6/18/25 4:01:37 PM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • SEC Form DEF 14A filed by SBC Medical Group Holdings Incorporated

      DEF 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

      5/28/25 6:07:42 AM ET
      $SBC
      Medical/Nursing Services
      Health Care

    $SBC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Yamazaki Miki

      3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

      4/18/25 4:56:42 PM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • Amendment: New insider Aikawa Yoshiyuki claimed ownership of 94,192,433 shares (SEC Form 3)

      3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)

      4/9/25 7:00:13 AM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • Director Sayama Mike K acquired 15,000 shares (SEC Form 4)

      4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

      9/30/24 4:25:27 PM ET
      $SBC
      Medical/Nursing Services
      Health Care

    $SBC
    Leadership Updates

    Live Leadership Updates

    See more
    • SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

      IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

      7/1/25 8:00:00 AM ET
      $SBC
      Medical/Nursing Services
      Health Care

    $SBC
    Financials

    Live finance-specific insights

    See more
    • SBC Medical Group Holdings Announces First Quarter 2025 Financial Results

      SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the three months ended March 31, 2025. First Quarter 2025 Highlights Total revenues were $47 million, representing a 14% year-over-year decrease. Income from operations was $24 million, representing a 1% year-over-year decrease. Net Income attributable to SBC Medical Group was $22 million, representing a 15% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of

      5/15/25 7:30:00 AM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • SBC Medical Group Holdings Announces Approval of Share Repurchase Program and Commencement of Share Repurchases

      IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, "the Company") today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025. Share Repurchase Program Maximum aggregate amount: US $5 millionImplementation period: May 20, 2025 – May 20, 2026Funding source: Surplus cash and future free cash flow The Company believes its current share price undervalues its business performance, the growth potential of the aesthetic‑medical market, and its position as an industry leader. Based on this view, it has decided to purchase shares on the ope

      5/15/25 7:00:00 AM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • SBC Medical Group Holdings Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

      SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for -the three months ended December 31, 2024 and full year 2024. Fourth Quarter 2024 Highlights Total revenues were $44 million, representing a 29% year-over-year decrease. Gross profit was $34 million, representing a 22% year-over-year decrease. Income from operations was $5 million, representing an 80% year-over-year decrease. EBITDA1, which is calculated by adding depreciation and amortization expense and impairment loss to income from operations was $

      3/28/25 7:00:00 AM ET
      $SBC
      Medical/Nursing Services
      Health Care

    $SBC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

      SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

      10/1/24 9:00:18 PM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

      SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

      9/24/24 9:07:03 PM ET
      $SBC
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

      SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

      9/23/24 9:02:53 AM ET
      $SBC
      Medical/Nursing Services
      Health Care